aTYR PHARMA INC Stock Split Ratio
aTYR PHARMA INC (ATYR) reported Stock Split Ratio of 795.41% for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Notes
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2016-03-30
- aTYR PHARMA INC stockholders' equity note, stock split, conversion ratio for the quarter ending 2015-03-31 was 795.41%.
- aTYR PHARMA INC stockholders' equity note, stock split, conversion ratio for fiscal 2015 was 795.41%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|---|
| 2015-12-31 | 795.41% 10-K · filed 2016-03-30 | |||
| 2015-09-30 | 795.41% 10-Q · filed 2015-11-10 | |||
| 2015-06-30 | 795.41% 10-Q · filed 2015-08-12 | |||
| 2015-03-31 | 795.41% 10-Q · filed 2015-06-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |